H. Mager

Resampling Methods in Sparse Sampling Situations in Preclinical Pharmacokinetic Studies

H. Mager, Gernot Göller · Journal of Pharmaceutical Sciences · 1998 · 38 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

Biostatistical Methodology in Carcinogenicity Studies

William R. Fairweather, Amit Bhattacharyya, Peter Ceuppens et al. · Drug Information Journal · 1998 · 27 citations · Full text

Medicine, Biostatistics, Toxicology +12

Variability in the reproductive performance of beneficial insects in standard laboratory toxicity assays ‐ Implications for hazard classification of pesticides

Richard A. Schmuck, H. Mager, C. Künast et al. · Annals of Applied Biology · 1996 · 24 citations

Veterinary Medicine, Entomology, Toxicology +17

Cautions regarding the physical interpretation of statistically based separation of the ortho substituent effect into inductive, mesomeric, and steric components—I

H. Mager, Peter P. Mager, A. Barth · Tetrahedron · 1979 · 20 citations

Pharmacy, Chemistry, Physical Chemistry +5

Determination of urinary glutathione S-transferase and lactate dehydrogenase for differentiation between proximal and distal nephron damage

E. Bomhard, D Maruhn, Otto Vogel et al. · Archives of Toxicology · 1990 · 20 citations

Medicine, Biochemistry, Nephrology +14